Mallinckrodt Completes Acquisition Of Therakos, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- US stock index futures slip as high-stakes Iran, inflation tests loom
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
Mallinckrodt (MNK) Completes $1.33B Acquisition of Therakos
September 28, 2015 6:50 AM EDTMallinckrodt (NYSE: MNK) announced that it has completed its acquisition of Therakos, Inc., from The Gores Group at a purchase price of approximately $1.325 billion. The Therakos acquisition further broadens Mallinckrodt's footprint in hospitals expanding its reach into immunotherapy through extracorporeal photopheresis (ECP) and extending the company's presence from multimodal surgical pain management and critical care respiratory therapies in... More
